Six weeks of supplementation with the probiotic-enzyme mix led to 150- and 175-fold decreases in potential pathogens Bacillus thuringiensis and Macrococcus caseolyticus, reported scientists from Case Western Reserve College in Cleveland, Ohio.
“The rise in S. cerevisiae abundance following probiotic-amylase mix supplementation is a sturdy proof of idea that oral probiotic consumption leads to long-lasting adjustments within the microbial composition of the intestine microbiota,” they wrote within the journal Life.
“The potential well being advantages of consuming S. cerevisiae var. boulardii […] embody modulating intestinal irritation in addition to bettering host immune response. S. cerevisiae is a flexible fungal organism with wide-ranging scientific and helpful well being implications.”
The research was co-funded by Cleveland-based Biohm Well being and the Nationwide Institute of Allergy and infectious Ailments. Lead writer Dr. Mahmoud Ghannoum, director of medical mycology at Case Western Reserve College, can also be co-founder of Biohm Well being.
Biohm CEO: ‘Thrilling instances forward!’
Commenting on the analysis, Sam Schatz, CEO of Biohm Well being, stated: “That is what occurs while you use highly effective information, a powerful speculation on the underlying mechanism of motion and world-class science to develop a subsequent technology probiotic ingredient.
“Our distinctive AI Symbiont platform will speed up and improve the formulation and discovery course of, leveraging our distinctive and proprietary information and our pioneering crew of dietitians, bioinformaticians, scientists and product builders. Thrilling instances forward!”
